Importantly, we will have to address key mechanistic questions such as whether perturbing Pfn1 affects the secretion of matrix-degrading proteolytic enzymes (an integral aspect of cell invasion) or primes tumour cells to preferentially adapt to any special kind of motility (mesenchymal vs ameboid) during the process of invasion. The gene discussed is PFN1; the disease is neoplasm.